Ultrasound Imaging of Anatomical StructuresNCT04906018
A Study to Collect Imaging Data for the Validation of the Intelligent Ultrasound's ScanNav Anatomy Peripheral Nerve Block (PNB) - US v1.0
An observational study of Ultrasound Imaging of Anatomical Structures, run by IntelligentUltrasound Limited at 1 site in United States.
Trial summary
This is a single-center, prospective study to be undertaken at University of Oregon, Portland, USA. The aim is to evaluate the clinical performance of ScanNav Anatomy PNB when highlighting anatomical structures during UGRA scanning. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Ultrasound Imaging of Anatomical Structures
- What is being tested?
- Ultrasound scans
- Type of treatment
- Medical device
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 16 May 2021to 30 Nov 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Study population: Potential study subjects will be healthy volunteers, chosen to provide a variety of ages and BMIs. Subjects will be screened to ensure approximate equal numbers in coverage for BMI (<30, 30-39) category.
Who may be able to join
- Male or female, at least 18 years of age;
- Able to comprehend and sign the Informed Consent prior to enrolment in the study.
- Vaccinated against SARS-CoV-2
Who cannot join
- Aged <18 years of age;
- Unwilling or unable to provide informed consent.
- BMI> 39 kg/m2
- Known pathology of the area to be scanned
Trial locations and contacts
1 site in 1 country.
United States1 site
Oregon Health & Science University
Portland, Oregon, 97239
About this study
This is a single-center, prospective study to be undertaken at University of Oregon, Portland, USA. The aim is to evaluate the clinical performance of ScanNav Anatomy PNB when highlighting anatomical structures during UGRA scanning. Specifically, we aim to assess and quantify the correct/incorrect highlighting of anatomical structures associated with ScanNav Anatomy PNB during UGRA scanning.
Read the detailed description
Background:
The American Society of Regional Anesthesia and Pain Medicine (ASRA) has published evidence-based assessment of ultrasound-guided regional anesthesia (Neal et al., 2010) concluding that ultrasound guidance is superior or equal to other non-ultrasound nerve localization techniques. A subsequent publication from ASRA (Neal et al., 2016), has strengthened their position of ultrasound guidance being superior than other methods, including for the reduction of local anesthetic systemic toxicity. However, ultrasound-guided regional anesthesia (UGRA) is a difficult technique to master. A key activity of UGRA is ultrasound image interpretation (Sites et al., 2009) which ScanNav Anatomy PNB is designed to support. The data collected during this study will be assessed by a panel of intended users (experts in UGRA) to evaluate the performance and safety of ScanNav Anatomy PNB device highlighting.
Statistical Methodology:
Validation analyses will be conducted once the data collection has been complete. The collected scans will be processed, and the device output will be generated post hoc. Device output will be presented with raw ultrasound side-by-side. A panel of at least three expert anesthesiologists will review and evaluate each processed scan. The majority view of the panel will be used to evaluate each endpoint for any given structure ScanNav Anatomy PNB is intended to highlight.
Data collection and scan processing:
40 different subjects will be scanned. The dataset will be balanced to contain approximately equal numbers of subjects with BMI<30 and BMI>= 30 kg/m2.
All data collection will be performed with FDA cleared general purpose ultrasound machine, ScanNav Anatomy PNB device will not be used during data collection.
Data characteristics for scan subjects (e.g., age and BMI) will be reported. Ultrasound scans for all 9 supported anatomical regions will be collected from both sides of each subject.
90 x 10s clips per supported anatomical region will be generated, consisting of:
- 80 x 10s scene clips: the block view (chosen by the expert scanner) together with the preceding 10 seconds of ultrasound scanning will be recorded (without the use of ScanNav Anatomy PNB)
- 10 x 10s non-scene clips: 10 second ultrasound scans will be recorded at non-optimum block views, chosen by the expert scanner to represent plausible scanning errors (without the use of ScanNav Anatomy PNB) Scenes and non-scenes will be analyzed separately. Unmodified ultrasound video and highlighted video (color overlay produced by ScanNav Anatomy PNB generated post-hoc) will be presented side-by-side to independent experts for data analysis.
Data analysis:
Every clip will be presented to a minimum of 3 independent expert reviewers. All clips from a single anatomical region will be reviewed by the same 3 reviewers. Experts may review more than one anatomical region, but not necessarily all anatomical regions. Thus, a range of experts will review all anatomical regions.
Reviewers will be asked structured questions to assess the highlighting of safety critical anatomical structures (see definitions later in document) and the performance of ScanNav Anatomy PNB output for each individual clip.
The majority opinion (at least 2/3) will be obtained to establish the overall panel opinion (e.g., yes/yes/no = yes) for each structure on each clip.
Data will be evaluated and presented by structure in each anatomical region and overall (i.e., total for each class; nerve, artery etc.).
Inter-rater agreement between the reviewers will be reported on an anatomical region basis.
Data will be presented as frequencies and presented as percent of total clips analyzed.
Data analysis will include stratification by subject age, BMI, and ultrasound machine to ensure consistency across these variables.
- Being tested
- Ultrasound scans
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ultrasound scansDevice
Each subject will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
| Study group | Role | What they receive |
|---|---|---|
| volunteer group - BMI less than 30 | Each subject with a BMI less than 30 will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions. Receives: Device: Ultrasound scans | |
| volunteer group - BMI of 30 and above | Each subject with a BMI of 30 and above will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions. Receives: Device: Ultrasound scans |
What is being measured
The primary outcome is the main question the study is designed to answer.
ScanNav Anatomy PNB highlighting misidentification of structures
Frequency of misidentification of structures [% of total, per anatomical region]
Measured: 6 months
Secondary outcomes (3)
ScanNav Anatomy PNB highlighting identification of structures
Frequency of correct identification of structures [% of total] and Frequency of non-identification of structures [% of total]
Measured: 6 months
ScanNav Anatomy PNB safety issues
Frequency of safety issues [% of total]
Measured: 6 months
ScanNav Anatomy PNB adverse events
Frequency of highlighting risking an adverse event [% of total]
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 May 2021
- Study start16 May 2021
- Primary completion16 May 2021
- Study completion30 Nov 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Ultrasound Imaging of Anatomical StructuresStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- IntelligentUltrasound Limited
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Glenn Woodworth, MD, Principal investigator, Oregon Health and Science UniversityJames Bowness, MD, Principal investigator, University of Oxford & Royal Gwent Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04906018
- Sponsor's protocol ID
- IU2021_AG_07
- Status last verified
- Jun 2021
- First submitted
- 25 May 2021
- Last updated
- 1 Apr 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Publications
Bowness JS, Burckett-St Laurent D, Hernandez N, Keane PA, Lobo C, Margetts S, Moka E, Pawa A, Rosenblatt M, Sleep N, Taylor A, Woodworth G, Vasalauskaite A, Noble JA, Higham H. Assistive artificial intelligence for ultrasound image interpretation in regional anaesthesia: an external validation study. Br J Anaesth. 2023 Feb;130(2):217-225. doi: 10.1016/j.bja.2022.06.031. Epub 2022 Aug 18.
PubMed 35987706
Study at a glance
From the registry record, last updated by the sponsor on 1 Apr 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Study to Collect Imaging Data for the Validation of the Intelligent Ultrasound's ScanNav Anatomy Peripheral Nerve Block (PNB) - US v1.0
- ClinicalTrials.gov ID
- NCT04906018
- Acronym / sponsor ID
- IU2021_AG_07
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- IntelligentUltrasound LimitedIndustry (pharma, biotech, devices)
- Study start
- 16 May 2021 (actual)
- Primary completion
- 16 May 2021 (actual)
- Study completion
- 30 Nov 2021 (actual)
- First posted
- 28 May 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a single-center, prospective study to be undertaken at University of Oregon, Portland, USA. The aim is to evaluate the clinical performance of ScanNav Anatomy PNB when highlighting anatomical structures during UGRA scanning. Specifically, we aim to assess and quantify the correct/incorrect highlighting of anatomical structures associated with ScanNav Anatomy PNB during UGRA scanning.
Detailed description
Background:
The American Society of Regional Anesthesia and Pain Medicine (ASRA) has published evidence-based assessment of ultrasound-guided regional anesthesia (Neal et al., 2010) concluding that ultrasound guidance is superior or equal to other non-ultrasound nerve localization techniques. A subsequent publication from ASRA (Neal et al., 2016), has strengthened their position of ultrasound guidance being superior than other methods, including for the reduction of local anesthetic systemic toxicity. However, ultrasound-guided regional anesthesia (UGRA) is a difficult technique to master. A key activity of UGRA is ultrasound image interpretation (Sites et al., 2009) which ScanNav Anatomy PNB is designed to support. The data collected during this study will be assessed by a panel of intended users (experts in UGRA) to evaluate the performance and safety of ScanNav Anatomy PNB device highlighting.
Statistical Methodology:
Validation analyses will be conducted once the data collection has been complete. The collected scans will be processed, and the device output will be generated post hoc. Device output will be presented with raw ultrasound side-by-side. A panel of at least three expert anesthesiologists will review and evaluate each processed scan. The majority view of the panel will be used to evaluate each endpoint for any given structure ScanNav Anatomy PNB is intended to highlight.
Data collection and scan processing:
40 different subjects will be scanned. The dataset will be balanced to contain approximately equal numbers of subjects with BMI<30 and BMI>= 30 kg/m2.
All data collection will be performed with FDA cleared general purpose ultrasound machine, ScanNav Anatomy PNB device will not be used during data collection.
Data characteristics for scan subjects (e.g., age and BMI) will be reported. Ultrasound scans for all 9 supported anatomical regions will be collected from both sides of each subject.
90 x 10s clips per supported anatomical region will be generated, consisting of:
- 80 x 10s scene clips: the block view (chosen by the expert scanner) together with the preceding 10 seconds of ultrasound scanning will be recorded (without the use of ScanNav Anatomy PNB)
- 10 x 10s non-scene clips: 10 second ultrasound scans will be recorded at non-optimum block views, chosen by the expert scanner to represent plausible scanning errors (without the use of ScanNav Anatomy PNB) Scenes and non-scenes will be analyzed separately. Unmodified ultrasound video and highlighted video (color overlay produced by ScanNav Anatomy PNB generated post-hoc) will be presented side-by-side to independent experts for data analysis.
Data analysis:
Every clip will be presented to a minimum of 3 independent expert reviewers. All clips from a single anatomical region will be reviewed by the same 3 reviewers. Experts may review more than one anatomical region, but not necessarily all anatomical regions. Thus, a range of experts will review all anatomical regions.
Reviewers will be asked structured questions to assess the highlighting of safety critical anatomical structures (see definitions later in document) and the performance of ScanNav Anatomy PNB output for each individual clip.
The majority opinion (at least 2/3) will be obtained to establish the overall panel opinion (e.g., yes/yes/no = yes) for each structure on each clip.
Data will be evaluated and presented by structure in each anatomical region and overall (i.e., total for each class; nerve, artery etc.).
Inter-rater agreement between the reviewers will be reported on an anatomical region basis.
Data will be presented as frequencies and presented as percent of total clips analyzed.
Data analysis will include stratification by subject age, BMI, and ultrasound machine to ensure consistency across these variables.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| volunteer group - BMI less than 30 | – | Device: Ultrasound scansEach subject with a BMI less than 30 will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions. |
| volunteer group - BMI of 30 and above | – | Device: Ultrasound scansEach subject with a BMI of 30 and above will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- Potential study subjects will be healthy volunteers, chosen to provide a variety of ages and BMIs. Subjects will be screened to ensure approximate equal numbers in coverage for BMI (<30, 30-39) category.
Key inclusion criteria (3 listed)
- Male or female, at least 18 years of age;
- Able to comprehend and sign the Informed Consent prior to enrolment in the study.
- Vaccinated against SARS-CoV-2
Key exclusion criteria (4 listed)
- Aged <18 years of age;
- Unwilling or unable to provide informed consent.
- BMI> 39 kg/m2
- Known pathology of the area to be scanned
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ultrasound scansEach subject will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions. | Device | volunteer group - BMI less than 30, volunteer group - BMI of 30 and above |
Primary outcome
ScanNav Anatomy PNB highlighting misidentification of structures
Time frame: 6 months
Frequency of misidentification of structures [% of total, per anatomical region]
3 secondary outcomes
ScanNav Anatomy PNB highlighting identification of structures
Time frame: 6 months
ScanNav Anatomy PNB safety issues
Time frame: 6 months
ScanNav Anatomy PNB adverse events
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Apr 2022.
- Derived from this study: PubMed 35987706Bowness JS, Burckett-St Laurent D, Hernandez N, Keane PA, Lobo C, Margetts S, Moka E, Pawa A, Rosenblatt M, Sleep N, Taylor A, Woodworth G, Vasalauskaite A, Noble JA, Higham H. Assistive artificial intelligence for ultrasound image interpretation in regional anaesthesia: an external validation study. Br J Anaesth. 2023 Feb;130(2):217-225. doi: 10.1016/j.bja.2022.06.031. Epub 2022 Aug 18.
- Individual participant dataSharing planned: No
Related trials for Ultrasound Imaging of Anatomical Structures
Not yet recruitingObservational study
Ultrasound Mapping of the Anatomical Relationship Between the Right Internal Jugular Vein and Carotid Artery
Internal Jugular Vein Anatomy, Common Carotid Artery Anatomy
Recruiting
UHFUS Characterization of Normal Lymphatic Anatomy
Breast Cancer
Not yet recruitingObservational study
Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource Settings
Cirrhosis of the Liver, Ascites
Active, not recruiting
The Use of Ultrasound to Assess the Airway Anatomy Regarding Pharyngeal Seal and Its Protective Role Throw a Chemical Test for Three Supraglottic Devices (ProSeal LMA, I-gel, and I-gel Plus)
Combining Ultrasound Assessment of Sealing Quality With Chemical Monitoring , May Provide Valuable Insights to Compare Effectiveness of Different SAD
Not yet recruitingObservational study
Agreement Between Artificial Intelligence and Anesthesiologists in Ultrasound-Guided Axillary Brachial Plexus Block
Ultrasound-Guided Nerve Block and Artificial Intelligence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Glenn Woodworth, MD principal investigator
Oregon Health and Science University
James Bowness, MD principal investigator
University of Oxford & Royal Gwent Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Ultrasound Imaging of Anatomical Structures, run by IntelligentUltrasound Limited at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
ScanNav Anatomy PNB highlighting misidentification of structures (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04906018, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2022.